Cerapedics announces FDA approval of PMA supplement based on two-year clinical data

Cerapedics announces FDA approval of PMA supplement based on two-year clinical data

WESTMINSTER -- Cerapedics, a private ortho-biologics company, announced the U.S. Food and Drug Administration (FDA) has approved the company's Premarket Approval (PMA) supplement for i-FACTOR... Read More

Tuesday November 19, 2019 0 comments Tags: Westminster, Cerapedics, Jeffrey Marx, Glen Kashuba

Cerapedics to expand Colorado HQ, more than double workforce

Cerapedics to expand Colorado HQ, more than double workforce

WESTMINSTER -- Cerapedics , a private ortho-biologics company, announced the expansion of the company's headquarters in theDenvermetropolitan area. Over the past 18 months, Cerapedics has... Read More

Tuesday July 9, 2019 0 comments Tags: Westminster, Cerapedics, Glen Kashuba, Edward Sawyer

Cerapedics appoints Patrick O’Connor VP of clinical and market development

Cerapedics appoints Patrick O’Connor VP of clinical and market development

WESTMINSTER -- Cerapedics , a privately-held orthobiologics company, today announced the appointment of Patrick O'Connor as VP of Clinical and Market Development. "We are pleased to welcome... Read More

Tuesday June 25, 2019 0 comments Tags: Westminster, Cerapedics, Patrick O'Connor, Jeffrey Marx

Cerapedics announces first patients enrolled in IDE clinical trial of P-15L Bone Graft for TLIF surgery

Cerapedics announces first patients enrolled in IDE clinical trial of P-15L Bone Graft for TLIF surgery

WESTMINSTER -- Cerapedics , a privately-held orthobiologics company, today announced the first patients have been enrolled in an investigational device exemption (IDE) clinical trial evaluating... Read More

Tuesday July 31, 2018 0 comments Tags: Westminster, Cerapedics, Glen Kashuba, P-15L Peptide Enhanced Bone Graft

Cerapedics announces closing of $22M financing round led by KCK Group

Cerapedics announces closing of $22M financing round led by KCK Group

WESTMINSTER -- Cerapedics , a privately-held orthobiologics company, announced the company completed a $22 million financing led by KCK Group, a family investment fund that focuses on innovative... Read More

Monday July 16, 2018 0 comments Tags: Westminster, Cerapedics, KCK Group, Glen Kashuba

 Cerapedics announces positive results of IVANOS bone graft study

Cerapedics announces positive results of IVANOS bone graft study

WESTMINSTER -- Cerapedics, a privately-held orthobiologics company, today announced results from the IVANOS study evaluating i-FACTOR Peptide Enhanced Bone Graft in lumbar posterolateral spine... Read More

Monday May 21, 2018 0 comments Tags: Westminster, Cerapedics, i-FACTOR, Glen Kashuba

INterview with Jeffrey Marx, Cerapedics president and COO

INterview with Jeffrey Marx, Cerapedics president and COO

Jeffrey (Jeff) G. Marx , Ph.D. is a senior executive with over 20 years of experience in the medical device space. His experience includes successful leadership roles spanning RD, business... Read More

Monday November 6, 2017 0 comments Tags: Denver, Jeffrey Marx, Cerapedics

Cerapedics appoints Doug Kohrs to board and names Antony Koblish chair

Cerapedics appoints Doug Kohrs to board and names Antony Koblish chair

WESTMINSTER -- Cerapedics , a privately-held orthobiologics company, announced the appointment of Doug Kohrs to the company's board of directors and the appointment of Antony Koblish as board... Read More

Wednesday October 25, 2017 0 comments Tags: Westminster, Cerapedics, Doug Kohrs, Antony Koblish, Glen Kashuba